Glycopyrrolate and cardiac dysrhythmias in geriatric patients after reversal of neuromuscular blockade

Canadian Anaesthetists’ Society Journal - Tập 26 - Trang 22-25 - 1979
Stanley Muravchick1, William D. Owens1, James A. Felts1
1Department of Anesthesiology, Washington University School of Medicine, St. Louis

Tóm tắt

The increase in cardiac muscarinic activity following injection of anticholinesterases can be minimized by the long-acting anticholinergic drug glycopyrrolate. In a series of 50 patients 65 years of age or older who had received glycopyrrolate (0.88 ± 0.15mg) mixed with neostigmine (4.40 ± 0.66 mg) or pyridostigmine (17.46 ± 2.92 mg) to antagonize neuromuscular blockade, the incidence of new postoperative cardiac dysrhythmias was 16 per cent. All dysrhythmias occurred in patients with pre-existing cardiovascular disease. There was no statistically significant relationship between the incidence of cardiac dysrhythmias and the choice of anaesthetic technique or anticholinesterase drug.

Tài liệu tham khảo

Rosner, V., Kepes, E.R., &Foldes, F.F. The effect of atropine and neostigmine on heart rate and rhythm. Br. J. Anaesth.43: 1066 (1971). Katz, R.L. Pyridostigmin (Mestinon) as an antagonist of d-tubocurarine. Anesthesiology28: 528 (1967). Owens, W.D., Waldbaum, L.S., &Stephen, C.R. Cardiac dysrhythmias following reversal of neuromuscular blocking agents in the geriatric patient. Anesth. Analg.57: 186 (1978). Miller, R.D., Von Nyhuis, L.S., Eger, E.I., Vitez, T.S., &Way, W.L. Comparative times to peak effect and durations of action of neostigmine and pyridostigmine. Anesthesiology41:27 (1974). Smith, CM., Mead, J.C., &Unna, K.R. Antagonism of d-tubocurarine III: time course of action of pyridostigmine, neostigmine, and edrophoniumin vivo andin vitro. J. Pharm. Exp. Therap.120: 215 (1957). Randall, L.O., Conroy, C.E., Ferriggia, T.M., Kappell, B.H., &Knoeppel, C.R. Pharmacology of the anticholinesterase drugs: Mestinon, Prostigmin, Tensilon and TEPP. Am. J. Med.19: 673 (1955). Osserman, K.E. Progress report on mestinon bromide (pyridostigmin bromide). Am. J. Med.19: 737 (1955). Fogdall, R.P. &Miller, R.D. Antagonism of d-tubocurarine and pancuronium induced neuromuscular blockade by pyridostigmine in man. Anesthesiology39: 504 (1973).